Safety Study of SGN-CD70A in Cancer Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Elaina Gartner, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- Cardinal Bernardin Cancer Center / Loyola University Medical Center
Maywood, Illinois, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute / Wayne State University
Detroit, Michigan, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- James P. Wilmot Cancer Center / University of Rochester Medical Center
Rochester, New York, United States
- Unc Lineberger Comprehensive Cancer Center / University of North Carolina
Chapel Hill, North Carolina, United States
- University of Cincinnati Cancer Institute
Cincinnati, Ohio, United States
- Case Western Reserve University / University Hospitals Case Medical Center
Cleveland, Ohio, United States
- University of Pennsylvania / Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina/hollings Cancer Center
Charleston, South Carolina, United States
- Texas Oncology - Austin Midtown
Austin, Texas, United States
- Methodist Cancer Center
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Seattle Cancer Care Alliance / University of Washington
Seattle, Washington, United States
- Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2014
- Primary completion
- 15 Feb 2017
- Completion
- 15 Feb 2017
- Last update posted
- 19 Apr 2018
- Registered enrollment
- 38
- Registry id
- NCT02216890
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.